Mengxin Wang, Stephen Vulcano, Changlu Xu, Renjian Xie, Weijie Peng, Jie Wang, . . . Yumei Li. (2024). Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment. Elsevier.
Chicago Style (17th ed.) CitationMengxin Wang, et al. Potentials of Ribosomopathy Gene as Pharmaceutical Targets for Cancer Treatment. Elsevier, 2024.
MLA (9th ed.) CitationMengxin Wang, et al. Potentials of Ribosomopathy Gene as Pharmaceutical Targets for Cancer Treatment. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.